Showing results (141-150 of 373) with videos related to
Sort By:
Pageof 38
Rheumatology (Oxford, England)|October 3, 2017
Interval between onset of psoriasis and psoriatic arthritis comparing the UK Clinical Practice Research Datalink with a hospital-based cohortWilliam Tillett, Rachel Charlton, Alison Nightingale, et al.The Journal of Rheumatology|July 7, 2026
Prologue: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2025 Annual MeetingDafna D Gladman, Wilson Bautista-Molano, Denis Poddubnyy, et al.Arthritis Research & Therapy|September 15, 2023
Nail psoriasis dynamics during biologic treatment and withdrawal in patients with psoriasis who may be at high risk of developing psoriatic arthritis: a post hoc analysis of the VOYAGE 2 randomized trialWilliam Tillett, Alexander Egeberg, Enikö Sonkoly, et al.Annals of the Rheumatic Diseases|January 8, 2013
Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritisWilliam Tillett, Deepak Jadon, Gavin Shaddick, et al.Frontiers in Medicine|July 7, 2023
Changes in musculoskeletal disease activity and patient-reported outcomes in patients with psoriatic arthritis treated with ixekizumab: results from a real-world US cohortWilliam Tillett, Julie Birt, Cristi Cavanaugh, et al.Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|October 23, 2023
Changing medication-related beliefs: A systematic review and meta-analysis of randomized controlled trialsElizabeth Sheils, William Tillett, Delyth James, et al.Clinical and Experimental Rheumatology|November 29, 2023
Patient clusters identified by machine learning from a pooled analysis of the clinical development programme of secukinumab in psoriatic arthritis, ankylosing spondylitis and psoriatic arthritis with axial manifestationsXenofon Baraliakos, Effie Pournara, Laura C Coates, et al.Clinical Rheumatology|December 17, 2016
An educational leaflet improves response to invitation for screening for arthritis in patients with psoriasis in primary care, but only in practices in the most deprived areasLaura C Coates, Laura Savage, Robin Waxman, et al.Rheumatology (Oxford, England)|December 6, 2018
Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumabLaura C Coates, Proton Rahman, Eliofotisti Psaradellis, et al.Rheumatology (Oxford, England)|January 5, 2019
Inhibition of radiographic progression in psoriatic arthritis by adalimumab independent of the control of clinical disease activityRobert Landewé, Christopher T Ritchlin, Daniel Aletaha, et al.Pageof 38